Citations

Clear

13603 citation(s) found for "_, _".

In nonsevere influenza, antiviral drugs do not reduce mortality or hospital admissions; some shorten symptom duration
Clements, Casey M. , Carpenter, Christopher R.

Mayo Clinic

Annals of Internal Medicine | May 5, 2025 | Volume: 178 | Issue: 5 | Pages: JC51

10.7326/annals-25-01324-jc | PMID 40324181 Get It

3D Printed Hollow Microneedles for Dermal and Transdermal Drug Delivery: Design, Fabrication, Application, and Perspective
Ghaznavi, Amirreza , Alavi, Sonia , Hara, Seth A. , Gemeinhart, Richard A. , Xu, Jie , Gemeinhart, Richard A , Xu, Jie , Lin, Yang

Mayo Clinic

Molecular Pharmaceutics | May 5, 2025 | Volume: 22 | Issue: 6 | Pages: 2747-2764

10.1021/acs.molpharmaceut.4c01261 | PMID 40323438 Get It

Proposed New MRI Scoring System of Rectosigmoid Endometriosis to Guide Operative Planning
Shahi, Maryam , Wang, Sherry S. , Li, Xiao , Çolak, Ceylan , Sheedy, Shannon P. , Bookwalter, Candice A., K, Feldman Myra, Khan, Zaraq , Johnson, Matthew P. , VanBuren, Wendaline M. , Takahashi, Hiroaki, Burnett, Tatnai L. , Jha, Priyanka , Feldman, Myra K,, Cope, Adela G.

Mayo Clinic

No container title available | May 5, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6336241/v1 Get It

Abstract Background: Rectosigmoid endometriosis (RSE) presents with a diverse array of MRI findings that impact surgical planning. No standardized reporting and data system has been established for RSE. Purpose: We propose a novel MRI scoring system designed to predict the likelihood of muscularis propria (MP) involvement in RSE, which would, in turn, influence surgical planning. Material and Methods: The records of patients with bowel endometriosis treated surgically from May 2018 to June 2022 were retrieved. Surgery was classified as partial thickness discoid, full thickness discoid, or segmental resection. Each pre-treatment MRI was scored based on the mutual agreement of two abdominal radiologists (reference score). The MRI score was defined as (1) score 0: no evidence of RSE, (2) score 1: minimal tethering involving the serosal surface without MP involvement, (3) score 2: intermediate soft tissue thickening involving the rectosigmoid colon with indeterminate MP involvement, or (4) score 3: definite mushroom cap sign or definite MP involvement. In the reader study, two radiologists independently scored each exam. The area under the curve (AUC) was evaluated for predicting the need for segmental or full thickness discoid resection. Results: The cohort consisted of 95 patients (median age: 36 years); 16, 14, 30, and 35 patients had MRI score 0, 1, 2, and 3, respectively. Patients with MRI scores 3 and 2 underwent partial thickness discoid (6% vs 50%), full thickness discoid (6% vs 17%), and segmental resection (89% vs 33%), respectively. All patients with MRI scores 1 or 0 either underwent partial thickness discoid resection or did not undergo rectosigmoid surgery. The AUCs were 92.2%, 84.5% and 93.9% for MRI scores of the reference, reader 1, and 2, respectively. Conclusion: Our MRI scoring system based on suspected depth of bowel invasion showed good diagnostic performance to predict the type of surgical intervention needed. Summary Statement This novel MRI scoring system for rectosigmoid endometriosis is a concise and qualitative scale based on suspected depth of bowel wall invasion to best guide operative planning.
Oncological Efficacy and Postoperative Outcomes of Low Grade Mucoepidermoid Carcinoma Treated With Partial Parotidectomy
Ali, Hasnat , Rourk, Katelyn S. , Byrne, Jamie O., Tasche, Kendall K. , Abel, Kathryn M. Van , Moore, Eric J. , Ali, Hawa M , Van Abel, Kathryn M , Yin, Linda X , Price, Daniel L. , Yin, Linda X.

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | May 5, 2025 | Volume: 134 | Issue: 8 | Pages: 606-612

10.1177/00034894251335405 | PMID 40320862 Get It

Objective: To assess the impact of extent of parotidectomy on surgical and oncologic outcomes in low grade mucoepidermoid carcinoma (LGMEC). Methods: A retrospective chart review of all patients undergoing primary surgical treatment for LGMEC from 2000 to 2022 was conducted. Clinical features collected included demographics, facial nerve function, operative techniques, postoperative complications/facial nerve function, and recurrence. Results: 58 patients were included; 10 patients underwent partial parotidectomy (PP), 38 underwent superficial parotidectomy (SP), and 10 underwent near-total/total parotidectomy. PP and SP patients had smaller tumors and more superficial tumors compared to near-total/total parotidectomy group ( P = .03). PP and SP were more likely to have negative margins and less locoregional disease compared to near-total/total parotidectomy patients ( P < .01). Near-total/total parotidectomy were more likely to undergo facial nerve resection (20% vs 0% for PP & SP respectively) ( P = .05). Immediate postoperative facial nerve function was significantly better among PP patients (73% HB I) compared to SP (44% HB I) and near-total/total parotidectomy patients (0% HB I) ( P < .01). Most patients regained their facial nerve function although only 40% of the near-total/total parotidectomy patients had a HB I at the time of last follow up ( P < .01). Patients were followed for a median of 6.2 years, during which only 1 patient (total parotidectomy) had a recurrence. Conclusions: PP offers a safe and effective approach for small LGMEC tumors, ensuring better facial nerve function postoperatively with minimal complications compared to more extensive surgery.
Single-cell multiomics identifies both shared and unique features of immune dysfunction in Parkinson’s disease and inflammatory bowel disease colon, plasma and stool
Bolen, MacKenzie L. , Buendia, Marie‐Annick , Shi, Ji , Staley, Hannah A. , Kachergus, Jennifer M., Efron, Philip A. , Park, Gwoncheol , Nagpal, Ravinder , Alvarez, Stephan D. , Xue, Qing‐Shan, McFarland, Nikolaus R. , Zimmermann, Ellen M. , Forsmark, Christopher E. , Thompson, E. Aubrey, Buendia, Marc , Staley, Hannah , Menees, Kelly B , Tansey, Malú G , McFarland, Nikolaus R , Buendia, Marc, Salas, Azucena , Thompson, E. Aubrey, Tansey, Malú G.

Mayo Clinic

No container title available | May 2, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.04.29.651228 | PMID 40661410 Get It

Abstract Parkinson’s disease (PD) is the fastest growing neurodegenerative disease in the world 1 . Gastrointestinal (GI) dysfunction can occur decades before motor impairments and in up to 80% of individuals living with PD 2,3,4 . We investigated peripheral relationships that may underlie mechanisms along the gut-blood axis that contribute to PD pathogenesis. Single-cell multiomic spatial molecular imaging (SMI) of colonic tissue localized inflammatory injury within epithelial cells that appear to be associated with iron mishandling in both inflammatory bowel disease (IBD) and PD biosamples. We found that both the single-cell SMI of RNA and protein revealed parallel cross-modal dysregulation in the gut epithelium, in both IBD and PD biosamples. These data are accompanied by plasma (PD) and stool (IBD) protein depletion of CCL22. Our findings suggest iron mishandling along the gut barrier likely contributes to systemic inflammation, which may be the catalyst that primes circulating immune cells to body-first PD pathogenesis.
Spinal anesthesia with mepivacaine versus bupivacaine: early start, same finish—an infographic
D’Souza, Ryan S. , Pillow, Clinton F , Amaral, Sara , D'Souza, Ryan S

Mayo Clinic

Regional Anesthesia & Pain Medicine | May 2, 2025 | Volume: 51 | Issue: 6 | Pages: 709-710

10.1136/rapm-2025-106710 | PMID 40316300 Get It

Introduction. Advances in spine tumor management: innovations in surgery, radiation, and biomarkers
Bilsky, Mark H. , Moraes, Fábio Ynoe de , Goodwin, C. Rory , Lubelski, Daniel , Clarke, Michelle J.

Mayo Clinic

Neurosurgical Focus | May 1, 2025 | Volume: 58 | Issue: 5 | Pages: E1

10.3171/2025.2.focus24672 Get It

AI-Powered Object Detection in Radiology: Current Models, Challenges, and Future Direction
Elhanashi, Abdussalam , Zheng, Qinghe , Almutairi, Nawal , Singh, Yashbir , Kuanar, Shiba , Ali, Farzana , Ünal, Orhan , Faghani, Shahriar , Zheng, Qinghe , Almutairi, Nawal , Singh, Yashbir , Ali, Farzana , Unal, Orhan , Faghani, Shahriar , Saponara, Sergio , Zheng, Qinghe

Mayo Clinic

Journal of Imaging | May 1, 2025 | Volume: 11 | Issue: 5 | Pages: 141

10.3390/jimaging11050141 | PMID 40422999 Get It

Artificial intelligence (AI)-based object detection in radiology can assist in clinical diagnosis and treatment planning. This article examines the AI-based object detection models currently used in many imaging modalities, including X-ray Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Ultrasound (US). The key models from the convolutional neural network (CNN) as well as the contemporary transformer and hybrid models are analyzed based on their ability to detect pathological features, such as tumors, lesions, and tissue abnormalities. In addition, this review offers a closer look at the strengths and weaknesses of these models in terms of accuracy, robustness, and speed in real clinical settings. The common issues related to these models, including limited data, annotation quality, and interpretability of AI decisions, are discussed in detail. Moreover, the need for strong applicable models across different populations and imaging modalities are addressed. The importance of privacy and ethics in general data use as well as safety and regulations for healthcare data are emphasized. The future potential of these models lies in their accessibility in low resource settings, usability in shared learning spaces while maintaining privacy, and improvement in diagnostic accuracy through multimodal learning. This review also highlights the importance of interdisciplinary collaboration among artificial intelligence researchers, radiologists, and policymakers. Such cooperation is essential to address current challenges and to fully realize the potential of AI-based object detection in radiology.
Pharmacologic features, clinical applications, and drug safety evaluation of futibatinib in the treatment of biliary tract cancer (BTC)
Pirozzi, Angelo , Hoyek, Celine , Okano, Naohiro , Rimassa, Lorenza, Usón, Pedro Luiz Serrano , Bekaii-Saab, Tanios S , Rimassa, Lorenza , Abidoye, Oluseyi , Sonbol, Mohamad Bassam , Uson, Pedro L S , Rimassa, Lorenza , Bekaii‐Saab, Tanios , Borad, Mitesh J.

Mayo Clinic

Expert Opinion on Drug Safety | May 1, 2025 | Volume: 24 | Issue: 12 | Pages: 1383-1390

10.1080/14740338.2025.2495178 | PMID 40307985 Get It